Estimate Recalculated Nov 1, 2024 10:04AM EST
Domain Partners VI, L.P. has an estimated net worth of $73.7 Million. This is based on reported shares across multiple companies, which include ZOGENIX, INC., CoLucid Pharmaceuticals, Inc., MARINUS PHARMACEUTICALS INC, Aldeyra Therapeutics, Inc., Vanda Pharmaceuticals Inc., Syndax Pharmaceuticals Inc, ALIMERA SCIENCES INC, Ocera Therapeutics, Inc., CADENCE PHARMACEUTICALS INC, Regado Biosciences Inc, Celator Pharmaceuticals Inc, and Somaxon Pharmaceuticals, Inc..
Domain Partners VI, L.P.'s CIK is 0001298033
2014 was Domain Partners VI, L.P.'s most active year for acquiring shares with 6 total transactions. Domain Partners VI, L.P.'s most active month to acquire stocks was the month of April. 2014 was Domain Partners VI, L.P.'s most active year for disposing of shares, totalling 12 transactions. Domain Partners VI, L.P.'s most active month to dispose stocks was the month of April. 2010 saw Domain Partners VI, L.P. paying a total of $4,158,308.00 for 4,839,667 shares, this is the most they've acquired in one year. In 2014 Domain Partners VI, L.P. cashed out on 3,816,009 shares for a total of $2,520,908.85, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!